414 related articles for article (PubMed ID: 12201210)
1. Comparison of ACTH secretion in Cushing's adenoma and clinically silent corticotroph adenoma by cell immunoblot assay.
Kojima Y; Suzuki S; Yamamura K; Ohhashi G; Yamamoto I
Endocr J; 2002 Jun; 49(3):285-92. PubMed ID: 12201210
[TBL] [Abstract][Full Text] [Related]
2. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
[TBL] [Abstract][Full Text] [Related]
4. Metyrapone pre-treated inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome.
Cuneo RC; Lee W; Harper J; Mitchell K; Ward G; Atkinson RL; Salkield I; Cameron DP
Clin Endocrinol (Oxf); 1997 May; 46(5):607-18. PubMed ID: 9231057
[TBL] [Abstract][Full Text] [Related]
5. High prolactin levels in patients with Cushing's disease without pathological evidence of pituitary adenoma.
Comtois R; Beauregard H; Hardy J; Robert F; Somma M
Clin Endocrinol (Oxf); 1993 Jun; 38(6):601-7. PubMed ID: 8392915
[TBL] [Abstract][Full Text] [Related]
6. Pro-opiomelanocortin gene expression in silent corticotroph-cell adenoma and Cushing's disease.
Nagaya T; Seo H; Kuwayama A; Sakurai T; Tsukamoto N; Nakane T; Sugita K; Matsui N
J Neurosurg; 1990 Feb; 72(2):262-7. PubMed ID: 2153197
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology and treatment of subclinical Cushing's disease and pituitary silent corticotroph adenomas [Review].
Kageyama K; Oki Y; Nigawara T; Suda T; Daimon M
Endocr J; 2014; 61(10):941-8. PubMed ID: 24974880
[TBL] [Abstract][Full Text] [Related]
8. The expression of glucocorticoid and mineralocorticoid receptors in pituitary tumors causing Cushing's disease and silent corticotroph tumors.
Kober P; Rusetska N; Mossakowska BJ; Maksymowicz M; Pękul M; Zieliński G; Styk A; Kunicki J; Działach Ł; Witek P; Bujko M
Front Endocrinol (Lausanne); 2023; 14():1124646. PubMed ID: 37065760
[TBL] [Abstract][Full Text] [Related]
9. Clinical Parameters of Silent Corticotroph Adenomas With Positive and Negative Adrenocorticotropic Hormone Immunostaining: A Large Retrospective Single-Center Study of 105 Cases.
Zhang K; Shou X; Chen H; Qiao N; He W; Chen Z; Shen M; Li S; Zhao Y; Zhang Z; Li Y; Ye H; Wang Y
Front Endocrinol (Lausanne); 2020; 11():608691. PubMed ID: 33584540
[TBL] [Abstract][Full Text] [Related]
10. Occult eutopic Cushing's syndrome--failure of simultaneous bilateral petrosal sinus sampling to diagnose pituitary-dependent Cushing's syndrome.
Heppner C; Becker K; Saeger W; Günther RW; Allolio B; Krone W; Winkelmann W
Eur J Endocrinol; 1997 Jul; 137(1):74-8. PubMed ID: 9242205
[TBL] [Abstract][Full Text] [Related]
11. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.
Chrousos GP; Schulte HM; Oldfield EH; Gold PW; Cutler GB; Loriaux DL
N Engl J Med; 1984 Mar; 310(10):622-6. PubMed ID: 6319991
[TBL] [Abstract][Full Text] [Related]
12. Significance of absent prohormone convertase 1/3 in inducing clinically silent corticotroph pituitary adenoma of subtype I--immunohistochemical study.
Ohta S; Nishizawa S; Oki Y; Yokoyama T; Namba H
Pituitary; 2002; 5(4):221-3. PubMed ID: 14558669
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical properties of silent corticotroph adenoma and Cushing's disease.
Iino K; Oki Y; Matsushita F; Yamashita M; Hayashi C; Miura K; Nishizawa S; Nakamura H
Pituitary; 2007; 10(1):35-45. PubMed ID: 17410413
[TBL] [Abstract][Full Text] [Related]
14. The role of bilateral inferior petrosal sinus sampling in the diagnosis of Cushing's syndrome.
Utz A; Biller BM
Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1329-38. PubMed ID: 18209871
[TBL] [Abstract][Full Text] [Related]
15. Electron microscopical morphometry of well-differentiated and undifferentiated ACTH secreting adenomas in Cushing's disease and Nelson's syndrome.
Reuss WA; Saeger W; Lüdecke DK
Virchows Arch A Pathol Anat Histopathol; 1991; 419(5):395-401. PubMed ID: 1661044
[TBL] [Abstract][Full Text] [Related]
16. Infrasellar pituitary gangliocytoma causing Cushing's syndrome.
Domingue ME; Marbaix E; Do Rego JL; Col V; Raftopoulos C; Duprez T; Vaudry H; Maiter D
Pituitary; 2015 Oct; 18(5):738-44. PubMed ID: 25183169
[TBL] [Abstract][Full Text] [Related]
17. Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess.
Colombo P; Passini E; Re T; Faglia G; Ambrosi B
Clin Endocrinol (Oxf); 1997 Jun; 46(6):661-8. PubMed ID: 9274696
[TBL] [Abstract][Full Text] [Related]
18. Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease.
Raverot G; Wierinckx A; Jouanneau E; Auger C; Borson-Chazot F; Lachuer J; Pugeat M; Trouillas J
Eur J Endocrinol; 2010 Jul; 163(1):35-43. PubMed ID: 20385723
[TBL] [Abstract][Full Text] [Related]
19. Cushing's syndrome with a large pituitary adenoma producing both corticotropin-releasing hormone (CRH) and adrenocorticotropin (ACTH).
Yamada Y; Ohashi A; Inoue T; Sakaguchi K; Tsujimura T; Okamoto D; Itatani H; Fujimoto N; Kusaka K; Fushimi H
Intern Med; 2002 Jul; 41(7):549-54. PubMed ID: 12132523
[TBL] [Abstract][Full Text] [Related]
20. Complications after transsphenoidal surgery for patients with Cushing's disease and silent corticotroph adenomas.
Smith TR; Hulou MM; Huang KT; Nery B; de Moura SM; Cote DJ; Laws ER
Neurosurg Focus; 2015 Feb; 38(2):E12. PubMed ID: 25639314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]